Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Comparative effectiveness inventory

This article was originally published in The Gray Sheet

Executive Summary

The Department of Health and Human Services is 1requesting public comment through Aug. 9 on development of a comparative effectiveness research "inventory" of ongoing and completed research for public consumption. HHS agencies have posted information on research projects stemming from the $1.1 billion in comparative effectiveness funding provided by economic stimulus legislation (2"The Gray Sheet" Jan. 11, 2010), but the agency is trying to develop a more comprehensive and accessible database. Comments are requested on appropriate sources of research for inclusion in the inventory, incentives for encouraging participation, methods for categorizing content and strategies to ensure that the inventory is "useful and sustainable over time.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT029161

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel